sulfasalazine has been researched along with Benign Cerebellar Neoplasms in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the importance of NFκB to medulloblastoma cell growth, the effects of multiple drugs that inhibit NFκB, pyrrolidine dithiocarbamate, diethyldithiocarbamate, sulfasalazine, curcumin and bortezomib, were studied in medulloblastoma cell lines compared to a malignant glioma cell line and normal neurons." | 3.77 | Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo. ( Deckard, LA; Logsdon, NJ; Sontheimer, H; Spiller, SE, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spiller, SE | 1 |
| Logsdon, NJ | 1 |
| Deckard, LA | 1 |
| Sontheimer, H | 1 |
1 other study available for sulfasalazine and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.
Topics: Animals; Boronic Acids; Bortezomib; Cell Growth Processes; Cell Line, Tumor; Cerebellar Neoplasms; C | 2011 |